Aarhus University Hospital

At Aarhus University Hospital, clinical research in these therapeutic areas focuses on the link between cardiovascular health and neurological injury, with a strong emphasis on conditions that affect blood flow to the brain.

• Ischemic stroke is the main disease under study, reflecting interest in improving outcomes after disrupted cerebral circulation.
• Trials are exploring whether new treatments can support recovery and reduce complications in the acute phase of stroke.
• Research also aims to better understand how therapies may protect both the brain and the wider vascular system.

This work is centered on testing new treatment approaches and evaluating their safety and effectiveness for people affected by acute stroke.

The Department of Neurology at this site is conducting clinical trials that concentrate on urgent treatment needs in ischemic stroke, with the goal of improving care during the earliest and most critical stage of illness.

• Research is directed at identifying therapies that may improve neurological recovery after stroke.
• Studies are also assessing whether a new intervention can be safely used soon after the event.
• The overall focus is on advancing treatment options for patients with acute brain ischemia.

One example is the ASSET Trial, which is examining whether semaglutide may be helpful in the acute phase after stroke.

Clinical trial activity at Aarhus University Hospital includes research into new ways to manage acute ischemic stroke, combining expertise in neurology and vascular disease.

• The main disease focus is ischemic stroke, a major cause of disability and long-term neurological impairment.
• Trials are designed to test whether emerging therapies can improve patient outcomes after stroke.
• There is also interest in understanding the broader role of metabolic and cardiovascular treatments in brain recovery.

These studies are intended to support better treatment decisions and expand the options available for patients in the acute setting.